Clinical trial
Host-pathogen Interactions, Immune Response, and Clinical Prognosis at COVID-19 - the CoVUm Trial
NCT04368013 is registered in ClinicalTrials.gov with Johan Normark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Host-pathogen Interactions, Immune Response, and Clinical Prognosis at COVID-19 - the CoVUm Trial
- Lead sponsor
- Johan Normark
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 28, 2020
- Completion date
- April 14, 2026
- Enrollment
- 550 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.